Prognostic factors and treatment of pediatric acute lymphoblastic leukemia
Jae Wook Lee, Bin Cho
Clin Exp Pediatr. 2017;60(5):129-137.   Published online 2017 May 31     DOI: https://doi.org/10.3345/kjp.2017.60.5.129
Citations to this article as recorded by Crossref logo
Prevalence and Clinical Outcome of Philadelphia-Like Acute Lymphoblastic Leukemia: Systematic Review and Meta-analysis
Weerapat Owattanapanich, Pongprueth Rujirachun, Patompong Ungprasert, Jassada Buaboonnam, Piti Techavichit
Clinical Lymphoma Myeloma and Leukemia.2020; 20(1): e22.     CrossRef
The effect of decitabine on the expression and methylation of thePPP1CA,BTG2, andPTENin association with changes in miR‐125b, miR‐17, and miR‐181b in NALM6 cell line
Asma Vafadar, Pooneh Mokaram, Mehran Erfani, Zahra Yousefi, Ali Farhadi, Tehrani Elham Shirazi, Gholamhossein Tamaddon
Journal of Cellular Biochemistry.2019; 120(8): 13156.     CrossRef
Influence of value of minimal residual disease at risk of developing recurrence of relapse in patients with acute lymphoblastic leukemia
E. A. Stolyarova, N. V. Migal, M. V. Belevtsev, L. V. Movchan, O. I. Budanov, A. M. Popov, L. G. Fechina, O, V. Aleinikova
Proceedings of the National Academy of Sciences of.2019; 16(2): 202.     CrossRef
Clinical characteristics and analysis of treatment result in children with Ph-positive acute lymphoblastic leukaemia in Poland between 2005 and 2017
Joanna Zawitkowska, Monika Lejman, Agnieszka Zaucha-Prażmo, Katarzyna Drabko, Marcin Płonowski, Joanna Bulsa, Michał Romiszewski, Agnieszka Mizia-Malarz, Andrzej Kołtan, Katarzyna Derwich, Grażyna Karolczyk, Tomasz Ociepa, Magdalena Ćwiklińska, Joanna Tre
European Journal of Haematology.2018; 101(4): 542.     CrossRef